Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07279038 · ClinicalTrials.gov registry record
Pivotal U.S. Clinical Validation of AI-COA® for Depression and Anxiety
A clinical trial, sponsored by Deliberate Solutions.
- Not yet
- Registry status
- 650
- Enrollment target
NCT07279038 is a clinical trial that has not yet begun recruiting, run by Deliberate Solutions. The registered enrollment target is 650 participants.
The verdict
NCT07279038 has not yet begun recruiting, sponsored by Deliberate Solutions.
- NOT YET RECRUITING
- Registry status
- 650 participants
- Enrollment target
Study Summary
This study is a large-scale pivotal clinical validation of the AI-COA® software device. The purpose is to confirm the tool's accuracy and performance across a demographically diverse population of adults with Major Depressive Disorder (MDD), ensuring it functions fairly and reliably across different subgroups.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 650 participants |
| Start Date | 2027-03-01 |
| Est. Completion | 2029-08-28 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07279038
The ClinicalTrials.gov registry entry for NCT07279038 describes a study currently listed as not yet recruiting, categorized as an unspecified phase. The registered enrollment target is 650 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Deliberate Solutions, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT07279038 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07279038 about?
NCT07279038 is a clinical study titled "Pivotal U.S. Clinical Validation of AI-COA® for Depression and Anxiety". This study is a large-scale pivotal clinical validation of the AI-COA® software device. The purpose is to confirm the tool's accuracy and performance across a demographically diverse population of adults with Major Depressive Disorder (MDD), ensuring it functions fairly and reliably across different...
What is the current status of trial NCT07279038?
This trial is currently not yet recruiting. The enrollment target is 650 participants. The study started on 2027-03-01. Estimated completion is 2029-08-28.
Who is sponsoring clinical trial NCT07279038?
This trial is sponsored by Deliberate Solutions, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.